US ENT Partners Announces Partnership with ProSomnus® Sleep Technologies to Advance Sleep Apnea Care
Dallas, TX, September 25, 2024 – US ENT Partners announced a new partnership with ProSomnus Sleep Technologies, the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™. This collaboration represents a significant advancement in providing Medical and Dental Sleep Medicine team members with cutting-edge therapy solutions designed to enhance OSA patient care and improve practice efficiency.
Key Benefits of the Partnership:
- US ENT’s expansive network of member practices will directly involve leading Dental Sleep Medicine Providers who are experienced prescribing ProSomnus devices to streamline access to high quality care for patients suffering from OSA.
- ProSomnus offers extensive support to seamlessly integrate their solutions into practices utilizing both the medical providers and sleep dentists expertise. This includes clinical education, reimbursement assistance, and marketing resources, all aimed at optimizing treatment offerings and promoting practice growth.
- ProSomnus continually pushes the boundaries of what is possible in sleep apnea treatment. By partnering with ProSomnus, US ENT Partners members remain at the forefront of this evolving field, providing patients with the latest in precision Oral Appliance Therapy.
- Both US ENT Partners and ProSomnus are dedicated to improving patient outcomes through innovative, evidence-based solutions. This partnership aligns with the shared goal of equipping ENT and Dental Sleep Medicine professionals with the tools and support necessary to deliver exceptional care.
“This new alignment between US ENT & ProSomnus, a leader in Oral Appliance Therapy for Obstructive Sleep Apnea, dramatically extends the reach for our Member Practices to provide this effective option for their sleep apnea patients,” stated Keith E. Matheny, MD, FARS, Chairman & Chief Executive Officer for US ENT Partners.
“ProSomnus is proud to partner with US ENT to expand access to care for the tens of millions of US adults suffering from Obstructive Sleep Apnea. US ENT has an impressive record of aligning with technological innovations that lower total treatment costs and enable member physicians to spend more time on patient care. ProSomnus precision Oral Appliance Therapy devices, in collaboration with leading Dental Sleep Medicine Providers, have clinically and scientifically demonstrated effective, safe and economical care for patients diagnosed with OSA,” stated Len Liptak, Chief Executive Office for ProSomnus Sleep Technologies.
This partnership with ProSomnus is expected to bring significant value to ENT practices, enabling them to offer the highest standard of care to patients with sleep apnea. For more information, visit US ENT at booth #2311 at the AAO-HNSF 2024 Annual Meeting & OTO EXPO taking place September 28-October 1 in Miami Beach, FL.
About US ENT Partners
Our founders, Keith Matheny and Jeff Gallant, established US ENT with a clear vision: to save ear, nose, and throat practices both time and money, allowing doctors and staff to focus on their patients. At US ENT, we strive to enhance practice operations, elevate patient care, and position ourselves as an industry-leading partner in the field of otolaryngology. To learn more, visit https://usent.com/.
About ProSomnus Sleep Technologies
ProSomnus Sleep Technologies is the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government-sponsored healthcare plans around the world, representing over 200 million covered lives. To learn more, visit www.ProSomnus.com.
Media Contacts
James Hermansen
US ENT Partners
Email: Jhermansen@usentpartners.com
Phone: +1.612.965.4890
Heather Whalen
ProSomnus Sleep Technologies
Email: HWhalen@ProSomnus.com
Phone: +1.925.360.2990